Correlation Between Ancorathelen Small and Goldman Sachs

Can any of the company-specific risk be diversified away by investing in both Ancorathelen Small and Goldman Sachs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ancorathelen Small and Goldman Sachs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ancorathelen Small Mid Cap and Goldman Sachs Emerging, you can compare the effects of market volatilities on Ancorathelen Small and Goldman Sachs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ancorathelen Small with a short position of Goldman Sachs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ancorathelen Small and Goldman Sachs.

Diversification Opportunities for Ancorathelen Small and Goldman Sachs

-0.1

Correlation Coefficient

Ancorathelen Small  Goldman Sachs

Good diversification

The 3 months correlation between Ancorathelen and Goldman is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Ancorathelen Small Mid Cap and Goldman Sachs Emerging in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Goldman Sachs Emerging and Ancorathelen Small is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ancorathelen Small Mid Cap are associated (or correlated) with Goldman Sachs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Goldman Sachs Emerging has no effect on the direction of Ancorathelen Small i.e., Ancorathelen Small and Goldman Sachs go up and down completely randomly.

Pair Corralation between Ancorathelen Small and Goldman Sachs

Assuming the 90 days horizon Ancorathelen Small Mid Cap is expected to generate 1.93 times more return on investment than Goldman Sachs. However, Ancorathelen Small is 1.93 times more volatile than Goldman Sachs Emerging. It trades about -0.02 of its potential returns per unit of risk. Goldman Sachs Emerging is currently generating about -0.19 per unit of risk. If you would invest  2,021  in Ancorathelen Small Mid Cap on October 8, 2024 and sell it today you would lose (57.00) from holding Ancorathelen Small Mid Cap or give up 2.82% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ancorathelen Small Mid Cap  vs.  Goldman Sachs Emerging

Ancorathelen Small Mid

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ancorathelen Small Mid Cap has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Ancorathelen Small is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Goldman Sachs Emerging

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Goldman Sachs Emerging has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Pair Trading with Ancorathelen Small and Goldman Sachs

The main advantage of trading using opposite Ancorathelen Small and Goldman Sachs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ancorathelen Small position performs unexpectedly, Goldman Sachs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Goldman Sachs will offset losses from the drop in Goldman Sachs' long position.

The idea behind Ancorathelen Small Mid Cap and Goldman Sachs Emerging pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.